These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37469482)

  • 1. A rat model of metabolic syndrome-related heart failure with preserved ejection fraction phenotype: pathological alterations and possible molecular mechanisms.
    Shi Y; Liu C; Yang C; Qiao W; Liu Y; Liu S; Dong G
    Front Cardiovasc Med; 2023; 10():1208370. PubMed ID: 37469482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sacubitril/valsartan attenuates myocardial inflammation, hypertrophy, and fibrosis in rats with heart failure with preserved ejection fraction.
    Shi YJ; Yang CG; Qiao WB; Liu YC; Liu SY; Dong GJ
    Eur J Pharmacol; 2023 Dec; 961():176170. PubMed ID: 37939991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ling-Gui-Qi-Hua formula alleviates left ventricular myocardial fibrosis in rats with heart failure with preserved ejection fraction by blocking the transforming growth factor-β1 /Smads signaling pathway.
    Shi Y; Liu C; Xiong S; Yang L; Yang C; Qiao W; Liu Y; Liu S; Liu J; Dong G
    J Ethnopharmacol; 2023 Dec; 317():116849. PubMed ID: 37385575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects and mechanism of Compound Qidan Formula on rats with HFpEF induced by hypertension and diabetes mellitus based on Ang Ⅱ/TGF-β1/Smads signaling pathway.
    Yuan P; Liu J; Xiong S; Yang L; Guan J; Dong G; Shi D
    J Ethnopharmacol; 2023 Sep; 313():116558. PubMed ID: 37116729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
    Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
    Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining three independent pathological stressors induces a heart failure with preserved ejection fraction phenotype.
    Li Y; Kubo H; Yu D; Yang Y; Johnson JP; Eaton DM; Berretta RM; Foster M; McKinsey TA; Yu J; Elrod JW; Chen X; Houser SR
    Am J Physiol Heart Circ Physiol; 2023 Apr; 324(4):H443-H460. PubMed ID: 36763506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Phenotypes of Heart Failure With Preserved Ejection Fraction to Select Preclinical Animal Models.
    van Ham WB; Kessler EL; Oerlemans MIFJ; Handoko ML; Sluijter JPG; van Veen TAB; den Ruijter HM; de Jager SCA
    JACC Basic Transl Sci; 2022 Aug; 7(8):844-857. PubMed ID: 36061340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction.
    Zhang L; Chen J; Yan L; He Q; Xie H; Chen M
    Front Pharmacol; 2021; 12():646240. PubMed ID: 34177571
    [No Abstract]   [Full Text] [Related]  

  • 10. A Preclinical Rat Model of Heart Failure With Preserved Ejection Fraction With Multiple Comorbidities.
    Hubesch G; Hanthazi A; Acheampong A; Chomette L; Lasolle H; Hupkens E; Jespers P; Vegh G; Wembonyama CWM; Verhoeven C; Dewachter C; Vachiery JL; Entee KM; Dewachter L
    Front Cardiovasc Med; 2021; 8():809885. PubMed ID: 35097026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qishen granule attenuates cardiac fibrosis by regulating TGF-β /Smad3 and GSK-3β pathway.
    Zeng Z; Wang Q; Yang X; Ren Y; Jiao S; Zhu Q; Guo D; Xia K; Wang Y; Li C; Wang W
    Phytomedicine; 2019 Sep; 62():152949. PubMed ID: 31102891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell therapy attenuates endothelial dysfunction in hypertensive rats with heart failure and preserved ejection fraction.
    de Couto G; Mesquita T; Wu X; Rajewski A; Huang F; Akhmerov A; Na N; Wu D; Wang Y; Li L; Tran M; Kilfoil P; Cingolani E; Marbán E
    Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H892-H903. PubMed ID: 36083797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular mechanisms of metabolic syndrome-related atrial decompensation in a rat model of HFpEF.
    Hohendanner F; Bode D; Primessnig U; Guthof T; Doerr R; Jeuthe S; Reimers S; Zhang K; Bach D; Wakula P; Pieske BM; Heinzel FR
    J Mol Cell Cardiol; 2018 Feb; 115():10-19. PubMed ID: 29289652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pressure Overload Activates DNA-Damage Response in Cardiac Stromal Cells: A Novel Mechanism Behind Heart Failure With Preserved Ejection Fraction?
    Stadiotti I; Santoro R; Scopece A; Pirola S; Guarino A; Polvani G; Maione AS; Ascione F; Li Q; Delia D; Foiani M; Pompilio G; Sommariva E
    Front Cardiovasc Med; 2022; 9():878268. PubMed ID: 35811699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiosphere-derived cells reverse heart failure with preserved ejection fraction (HFpEF) in rats by decreasing fibrosis and inflammation.
    Gallet R; de Couto G; Simsolo E; Valle J; Sun B; Liu W; Tseliou E; Zile MR; Marbán E
    JACC Basic Transl Sci; 2016; 1(1-2):14-28. PubMed ID: 27104217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction.
    Franssen C; Chen S; Unger A; Korkmaz HI; De Keulenaer GW; Tschöpe C; Leite-Moreira AF; Musters R; Niessen HW; Linke WA; Paulus WJ; Hamdani N
    JACC Heart Fail; 2016 Apr; 4(4):312-24. PubMed ID: 26682792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
    Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
    J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiomyocyte Functional Etiology in Heart Failure With Preserved Ejection Fraction Is Distinctive-A New Preclinical Model.
    Curl CL; Danes VR; Bell JR; Raaijmakers AJA; Ip WTK; Chandramouli C; Harding TW; Porrello ER; Erickson JR; Charchar FJ; Kompa AR; Edgley AJ; Crossman DJ; Soeller C; Mellor KM; Kalman JM; Harrap SB; Delbridge LMD
    J Am Heart Assoc; 2018 Jun; 7(11):. PubMed ID: 29858360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction.
    Lai YC; Tabima DM; Dube JJ; Hughan KS; Vanderpool RR; Goncharov DA; St Croix CM; Garcia-Ocaña A; Goncharova EA; Tofovic SP; Mora AL; Gladwin MT
    Circulation; 2016 Feb; 133(8):717-31. PubMed ID: 26813102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction.
    Schwarzl M; Hamdani N; Seiler S; Alogna A; Manninger M; Reilly S; Zirngast B; Kirsch A; Steendijk P; Verderber J; Zweiker D; Eller P; Höfler G; Schauer S; Eller K; Maechler H; Pieske BM; Linke WA; Casadei B; Post H
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1407-18. PubMed ID: 26342070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.